The impact of cardiac surgery in patients with trisomy 18 and trisomy 13 in Japan

Jun Maeda, Hiroyuki Yamagishi, Yoshiyuki Furutani, Mitsuhiro Kamisago, Tadashi Waragai, Shinji Oana, Hiroki Kajino, Hiroyuki Matsuura, Katsuhiko Mori, Rumiko Matsuoka, Toshio Nakanishi

Research output: Contribution to journalArticle

73 Citations (Scopus)

Abstract

Congenital heart defects (CHD) are very common in patients with trisomy 18 (T18) and trisomy 13 (T13). The surgical indication of CHD remains controversial since the natural history of these trisomies is documented to be poor. To investigate the outcome of CHD in patients with T18 and T13, we collected and evaluated clinical data from 134 patients with T18 and 27 patients with T13 through nationwide network of Japanese Society of Pediatric Cardiology and Cardiac Surgery. In patients with T18, 23 (17%) of 134 were alive at this survey. One hundred twenty-six (94%) of 134 patients had CHDs. The most common CHD was ventricular septal defect (VSD, 59%). Sixty-five (52%) of 126 patients with CHD developed pulmonary hypertension (PH). Thirty-two (25%) of 126 patients with CHD underwent cardiac surgery and 18 patients (56%) have survived beyond postoperative period. While palliative surgery was performed in most patients, six cases (19%) underwent intracardiac repair for VSD. Operated patients survived longer than those who did not have surgery (P<0.01). In patients with T13, 5 (19%) of 27 patients were alive during study period. Twenty-three (85%) of 27 patients had CHD and 13 (57%) of 27 patients had PH. Atrial septal defect was the most common form of CHD (22%). Cardiac surgery was done in 6 (26%) of 23 patients. In this study, approximately a quarter of patients underwent surgery for CHD in both trisomies. Cardiac surgery may improve survival in selected patients with T18.

Original languageEnglish
Pages (from-to)2641-2646
Number of pages6
JournalAmerican Journal of Medical Genetics, Part A
Volume155
Issue number11
DOIs
Publication statusPublished - 2011 Nov

Fingerprint

Thoracic Surgery
Japan
Congenital Heart Defects
Trisomy 18
Trisomy 13 syndrome
Trisomy
Pulmonary Hypertension
Atrial Heart Septal Defects
Ventricular Heart Septal Defects
Cardiology
Palliative Care
Postoperative Period

Keywords

  • Cardiac surgery
  • Trisomy 13
  • Trisomy 18

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

The impact of cardiac surgery in patients with trisomy 18 and trisomy 13 in Japan. / Maeda, Jun; Yamagishi, Hiroyuki; Furutani, Yoshiyuki; Kamisago, Mitsuhiro; Waragai, Tadashi; Oana, Shinji; Kajino, Hiroki; Matsuura, Hiroyuki; Mori, Katsuhiko; Matsuoka, Rumiko; Nakanishi, Toshio.

In: American Journal of Medical Genetics, Part A, Vol. 155, No. 11, 11.2011, p. 2641-2646.

Research output: Contribution to journalArticle

Maeda, J, Yamagishi, H, Furutani, Y, Kamisago, M, Waragai, T, Oana, S, Kajino, H, Matsuura, H, Mori, K, Matsuoka, R & Nakanishi, T 2011, 'The impact of cardiac surgery in patients with trisomy 18 and trisomy 13 in Japan', American Journal of Medical Genetics, Part A, vol. 155, no. 11, pp. 2641-2646. https://doi.org/10.1002/ajmg.a.34285
Maeda, Jun ; Yamagishi, Hiroyuki ; Furutani, Yoshiyuki ; Kamisago, Mitsuhiro ; Waragai, Tadashi ; Oana, Shinji ; Kajino, Hiroki ; Matsuura, Hiroyuki ; Mori, Katsuhiko ; Matsuoka, Rumiko ; Nakanishi, Toshio. / The impact of cardiac surgery in patients with trisomy 18 and trisomy 13 in Japan. In: American Journal of Medical Genetics, Part A. 2011 ; Vol. 155, No. 11. pp. 2641-2646.
@article{8eb13a8df1194852809ed098f1ed6c31,
title = "The impact of cardiac surgery in patients with trisomy 18 and trisomy 13 in Japan",
abstract = "Congenital heart defects (CHD) are very common in patients with trisomy 18 (T18) and trisomy 13 (T13). The surgical indication of CHD remains controversial since the natural history of these trisomies is documented to be poor. To investigate the outcome of CHD in patients with T18 and T13, we collected and evaluated clinical data from 134 patients with T18 and 27 patients with T13 through nationwide network of Japanese Society of Pediatric Cardiology and Cardiac Surgery. In patients with T18, 23 (17{\%}) of 134 were alive at this survey. One hundred twenty-six (94{\%}) of 134 patients had CHDs. The most common CHD was ventricular septal defect (VSD, 59{\%}). Sixty-five (52{\%}) of 126 patients with CHD developed pulmonary hypertension (PH). Thirty-two (25{\%}) of 126 patients with CHD underwent cardiac surgery and 18 patients (56{\%}) have survived beyond postoperative period. While palliative surgery was performed in most patients, six cases (19{\%}) underwent intracardiac repair for VSD. Operated patients survived longer than those who did not have surgery (P<0.01). In patients with T13, 5 (19{\%}) of 27 patients were alive during study period. Twenty-three (85{\%}) of 27 patients had CHD and 13 (57{\%}) of 27 patients had PH. Atrial septal defect was the most common form of CHD (22{\%}). Cardiac surgery was done in 6 (26{\%}) of 23 patients. In this study, approximately a quarter of patients underwent surgery for CHD in both trisomies. Cardiac surgery may improve survival in selected patients with T18.",
keywords = "Cardiac surgery, Trisomy 13, Trisomy 18",
author = "Jun Maeda and Hiroyuki Yamagishi and Yoshiyuki Furutani and Mitsuhiro Kamisago and Tadashi Waragai and Shinji Oana and Hiroki Kajino and Hiroyuki Matsuura and Katsuhiko Mori and Rumiko Matsuoka and Toshio Nakanishi",
year = "2011",
month = "11",
doi = "10.1002/ajmg.a.34285",
language = "English",
volume = "155",
pages = "2641--2646",
journal = "American Journal of Medical Genetics",
issn = "1552-4868",
publisher = "Wiley-Liss Inc.",
number = "11",

}

TY - JOUR

T1 - The impact of cardiac surgery in patients with trisomy 18 and trisomy 13 in Japan

AU - Maeda, Jun

AU - Yamagishi, Hiroyuki

AU - Furutani, Yoshiyuki

AU - Kamisago, Mitsuhiro

AU - Waragai, Tadashi

AU - Oana, Shinji

AU - Kajino, Hiroki

AU - Matsuura, Hiroyuki

AU - Mori, Katsuhiko

AU - Matsuoka, Rumiko

AU - Nakanishi, Toshio

PY - 2011/11

Y1 - 2011/11

N2 - Congenital heart defects (CHD) are very common in patients with trisomy 18 (T18) and trisomy 13 (T13). The surgical indication of CHD remains controversial since the natural history of these trisomies is documented to be poor. To investigate the outcome of CHD in patients with T18 and T13, we collected and evaluated clinical data from 134 patients with T18 and 27 patients with T13 through nationwide network of Japanese Society of Pediatric Cardiology and Cardiac Surgery. In patients with T18, 23 (17%) of 134 were alive at this survey. One hundred twenty-six (94%) of 134 patients had CHDs. The most common CHD was ventricular septal defect (VSD, 59%). Sixty-five (52%) of 126 patients with CHD developed pulmonary hypertension (PH). Thirty-two (25%) of 126 patients with CHD underwent cardiac surgery and 18 patients (56%) have survived beyond postoperative period. While palliative surgery was performed in most patients, six cases (19%) underwent intracardiac repair for VSD. Operated patients survived longer than those who did not have surgery (P<0.01). In patients with T13, 5 (19%) of 27 patients were alive during study period. Twenty-three (85%) of 27 patients had CHD and 13 (57%) of 27 patients had PH. Atrial septal defect was the most common form of CHD (22%). Cardiac surgery was done in 6 (26%) of 23 patients. In this study, approximately a quarter of patients underwent surgery for CHD in both trisomies. Cardiac surgery may improve survival in selected patients with T18.

AB - Congenital heart defects (CHD) are very common in patients with trisomy 18 (T18) and trisomy 13 (T13). The surgical indication of CHD remains controversial since the natural history of these trisomies is documented to be poor. To investigate the outcome of CHD in patients with T18 and T13, we collected and evaluated clinical data from 134 patients with T18 and 27 patients with T13 through nationwide network of Japanese Society of Pediatric Cardiology and Cardiac Surgery. In patients with T18, 23 (17%) of 134 were alive at this survey. One hundred twenty-six (94%) of 134 patients had CHDs. The most common CHD was ventricular septal defect (VSD, 59%). Sixty-five (52%) of 126 patients with CHD developed pulmonary hypertension (PH). Thirty-two (25%) of 126 patients with CHD underwent cardiac surgery and 18 patients (56%) have survived beyond postoperative period. While palliative surgery was performed in most patients, six cases (19%) underwent intracardiac repair for VSD. Operated patients survived longer than those who did not have surgery (P<0.01). In patients with T13, 5 (19%) of 27 patients were alive during study period. Twenty-three (85%) of 27 patients had CHD and 13 (57%) of 27 patients had PH. Atrial septal defect was the most common form of CHD (22%). Cardiac surgery was done in 6 (26%) of 23 patients. In this study, approximately a quarter of patients underwent surgery for CHD in both trisomies. Cardiac surgery may improve survival in selected patients with T18.

KW - Cardiac surgery

KW - Trisomy 13

KW - Trisomy 18

UR - http://www.scopus.com/inward/record.url?scp=80054892952&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80054892952&partnerID=8YFLogxK

U2 - 10.1002/ajmg.a.34285

DO - 10.1002/ajmg.a.34285

M3 - Article

VL - 155

SP - 2641

EP - 2646

JO - American Journal of Medical Genetics

JF - American Journal of Medical Genetics

SN - 1552-4868

IS - 11

ER -